Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Fuji
Healthtrust
Merck
Harvard Business School
QuintilesIMS
Express Scripts
Dow

Generated: August 18, 2018

DrugPatentWatch Database Preview

DEPAKOTE CP Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Depakote Cp patents expire, and what generic alternatives are available?

Depakote Cp is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in DEPAKOTE CP is divalproex sodium. There are seventeen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

Drug patent expirations by year for DEPAKOTE CP
Synonyms for DEPAKOTE CP
133299-66-8
644VL95AO6
76584-70-8
99-66-1 (Parent)
A838751
AB01568255_01
AB2000231
Abbott 50711
Abbott-50711
AC1Q1V4Q
AC1Q1VPW
AKOS015895200
AN-6581
API0002433
AS-17254
C-19234
C16H31NaO4
CC-27204
CHEBI:4667
CHEMBL2105613
D00304
D03LGY
Delepsine
Depacon (TN)
Depakote
Depakote (TN)
Depakote ER
Depakote ER (TN)
Depakote Sprinkle
Depakote;Epival
Divalproate
divalproex
DIVALPROEX SODIUM
Divalproex sodium (USP)
Divalproex sodium [USAN:USP]
Divalproex sodium [USAN]
Divalproex sodium salt
Divalproex sodium, Depakote, Epival
Divalproexsodium
DTXSID70227388
Epilex
Epival
Epival (TN)
Ergenyl Chrono (TN)
FT-0625375
HMS3651C17
I06-0339
LS-101863
MolPort-006-167-562
MSRILKIQRXUYCT-UHFFFAOYSA-M
Natrium hydrogen bis(2-propylvalerat)
OR339103
Pentanoic acid, 2-propyl-, sodium salt (2:1)
pentanoic acid, 2-propyl-, sodium salt(2:1)
potassium valproic acid dipropylacetate
s1703
SCHEMBL40996
Semisodium Valproate
Sodium 2-propylpentanoate 2-propylpentanoic acid
sodium 2-propylpentanoate--2-propylpentanoic acid (1:1)
Sodium 2-propylpentanoate-2-propylpentanoic acid (1:1)
Sodium divalproate
Sodium hydrogen bis(2-propylpentanoate)
Sodium hydrogen bis(2-propylvalerate)
Sodium hydrogen bis(2-propylvalerate), oligomer
Sodium hydrogen divalproate
sodium valproic acid valproate
sodium; 2-propylpentanoate; 2-propylpentanoic acid
Sprinkle
U058
UNII-644VL95AO6
Valance (TN)
Valcote
Valdisoval
Valparin
Valproate semisodique
Valproate semisodique [French]
Valproate semisodium
Valproate semisodium (INN)
Valproate semisodium [INN]
Valproato semisodico
Valproato semisodico [Spanish]
Valproatum seminatricum
Valproatum seminatricum [Latin]
Valproic acid semisodium salt (2:1)
Zalkote. (TN)

US Patents and Regulatory Information for DEPAKOTE CP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-001 Jul 11, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-002 Jul 11, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for DEPAKOTE CP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-001 Jul 11, 1990 ➤ Sign Up ➤ Sign Up
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-002 Jul 11, 1990 ➤ Sign Up ➤ Sign Up
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-001 Jul 11, 1990 ➤ Sign Up ➤ Sign Up
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-002 Jul 11, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Julphar
Cerilliant
Dow
Boehringer Ingelheim
Fish and Richardson
Cipla
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.